Adsorption of a Novel Recombinant Glycoprotein from HIV (Env gp120dV2 SF162) to Anionic PLG Microparticles Retains the Structural Integrity of the Protein, Whereas Encapsulation in PLG Microparticles Does Not-Reference-Cited by-同舟云学术

Adsorption of a Novel Recombinant Glycoprotein from HIV (Env gp120dV2 SF162) to Anionic PLG Microparticles Retains the Structural Integrity of the Protein, Whereas Encapsulation in PLG Microparticles Does Not

Published:2004-12 Issue:12 Volume:21 Page:2148-2152
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Singh Manmohan,Chesko James,Kazzaz Jina,Ugozzoli Mildred,Kan Elaine,Srivastava Indresh,O’Hagan Derek T.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-004-7666-6.pdf

Reference21 articles.

1. 1. E. A. Emini and W. C. Koff. Developing an AIDS vaccine: need, uncertainty, hope. Science 304:1913–1914 (2004).

2. 2. D. A. Garber, G. Silvestri, and M. B. Feinberg. Prospects for an AIDS vaccine: three big questions, no easy answers. Lancet Infect. Dis. 4:397–413 (2004).

3. 3. S. C. Sookoian. New therapies on the horizon for hepatitis C. Ann Hepatol. 2:164–170 (2003).

4. 4. S. E. Frey. HIV vaccines. Infectious Disease Clin. North America 13:95–112 (1999).

5. 5. J. Esparza. An HIV vaccine: how and when? Bull. World Health Organ. 79:1093 (2001).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained release system from PLGA particles co-encapsulated with inactivated influenza virus with natural killer T cell agonist α-galactosylceramide;European Journal of Pharmaceutics and Biopharmaceutics;2024-08

2. Rational design of polymer‐based particulate vaccine adjuvants;European Journal of Immunology;2023-12-03

3. Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases;Advanced NanoBiomed Research;2021-01-18

4. Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines;npj Vaccines;2020-09-18

5. In-vitro and in-vivo comparison of rSAG1-loaded PLGA prepared by encapsulation and adsorption methods as an efficient vaccine against Toxoplasma gondii”;Journal of Drug Delivery Science and Technology;2020-02